Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.(Bloomberg)

In bid to cure coronavirus, decade-old Actemra drug emerges as hope

By Reuters | Beijing/Zurich
UPDATED ON MAR 05, 2020 10:52 AM IST
Coronavirus update: China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.
Story Saved